What is Zacks Research's Estimate for Zoetis Q1 Earnings?

Zoetis Inc. (NYSE:ZTS - Free Report) - Zacks Research raised their Q1 2026 earnings estimates for shares of Zoetis in a report issued on Tuesday, December 3rd. Zacks Research analyst E. Bagri now forecasts that the company will earn $1.63 per share for the quarter, up from their prior estimate of $1.62. The consensus estimate for Zoetis' current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Zoetis' Q2 2026 earnings at $1.77 EPS and FY2026 earnings at $6.94 EPS.

Several other research firms also recently commented on ZTS. Leerink Partnrs raised Zoetis to a "strong-buy" rating in a research note on Monday, December 2nd. Leerink Partners initiated coverage on Zoetis in a report on Monday, December 2nd. They set an "outperform" rating and a $215.00 price target for the company. Argus raised shares of Zoetis to a "strong-buy" rating in a research note on Friday, August 9th. Piper Sandler upped their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a "buy" rating in a report on Wednesday, September 18th. Eleven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $220.80.

Zoetis Stock Performance

Shares of ZTS stock traded up $1.69 during trading hours on Friday, hitting $176.46. The stock had a trading volume of 2,551,210 shares, compared to its average volume of 2,604,876. The stock's 50 day moving average is $182.43 and its 200 day moving average is $180.93. The firm has a market capitalization of $79.61 billion, a PE ratio of 33.17, a PEG ratio of 2.86 and a beta of 0.89. Zoetis has a twelve month low of $144.80 and a twelve month high of $201.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. Zoetis's revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the business earned $1.36 EPS.

Institutional Trading of Zoetis

Several hedge funds and other institutional investors have recently bought and sold shares of ZTS. Simplify Asset Management Inc. acquired a new position in shares of Zoetis during the 3rd quarter valued at about $11,684,000. Bank Pictet & Cie Asia Ltd. raised its stake in Zoetis by 41.0% during the second quarter. Bank Pictet & Cie Asia Ltd. now owns 37,500 shares of the company's stock worth $6,501,000 after purchasing an additional 10,900 shares during the period. B&L Asset Management LLC acquired a new position in shares of Zoetis in the 3rd quarter valued at $563,000. Swedbank AB grew its stake in shares of Zoetis by 56.2% during the 2nd quarter. Swedbank AB now owns 1,946,277 shares of the company's stock valued at $337,407,000 after buying an additional 700,398 shares during the period. Finally, Dai ichi Life Insurance Company Ltd increased its holdings in shares of Zoetis by 16.3% during the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 74,499 shares of the company's stock worth $14,556,000 after buying an additional 10,427 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st were issued a dividend of $0.432 per share. The ex-dividend date was Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. Zoetis's dividend payout ratio (DPR) is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.